Comparison of whole exome sequencing and FoundationOne Heme sequencing panel as tools for precision oncology in paediatric patients with difficult-to-treat solid tumours

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

NOSKOVA H. ADAMCOVÁ Soňa KNOFLÍČKOVÁ Dana PÁL Karol GRIONI Andrea HORNAKOVA T. MERTA T. MUDRY P. PAVELKA Z. VEJMELKOVA K. STERBA J. SLABÝ Ondřej

Year of publication 2019
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Description The necessary condition for the application of precision oncology approach into the routine is a detailed molecular characterization of the tumour. In our study, we explored clinical applicability of both whole exome sequencing (WES) and FoundationOne Heme (F1Heme) panel (Foundation Medicine, Inc., MA, USA) as comprehensive genomic profiling tools in a cohort of 35 children with difficult-to-treat solid tumours.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.